Cell surface levels of the inhibitory NK receptor NKG2A39 were increased while levels of the activating NK receptors NKp30/80,57 KIR2DS1/3, and KIR2DS2/445 were decreased in pediatric cancer patients. Here, NCR3 is linked to cancer.